Literature DB >> 2650792

Fatal hepatitis B reactivation after autologous bone marrow transplantation.

A Webster1, M K Brenner, H G Prentice, P D Griffiths.   

Abstract

We report a fatal case of hepatitis B reactivation following autologous bone marrow transplantation for acute lymphocytic leukaemia. The presence of antibodies to HBs and HBc at presentation indicated previous infection with hepatitis B; these antibodies disappeared during the course of treatment for leukaemia. HBsAg was first detected in serum 5 weeks post-transplant; liver function tests began to deteriorate 8 weeks later, when HBeAg was first detected. The hepatitis followed a fulminant course, and the patient died 10 days later, in the 15th week following transplant.

Entities:  

Mesh:

Year:  1989        PMID: 2650792

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

1.  Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment.

Authors:  M Yoshiba; K Sekiyama; F Sugata; H Okamoto; K Yamamoto; S Yotsumoto
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

2.  Hepatitis B virus reactivation in a patient with chronic GVHD after allogeneic peripheral blood stem cell transplantation.

Authors:  H Sakamaki; Y Sato; S I Mori; K Ohashi; S Tanikawa; H Akiyama; T Sasaki; K Hiruma
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

3.  Retrospective study on the impact of hepatitis B and hepatitis C virus infection on hematopoietic stem cell transplantation in Japan.

Authors:  Motohiro Hamaguchi; Hironori Yamada; Hisashi Gondo; Yoshinobu Takemoto; Yasuo Morishima; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

4.  Acute hepatitis B despite a previous high titer of anti-HBs.

Authors:  Resat Ozaras; Cem Ar; Seniz Ongoren; Bilgul Mete; Fehmi Tabak; Ali Mert; Recep Ozturk
Journal:  Hepatol Int       Date:  2010-04-09       Impact factor: 6.047

Review 5.  Management of occult hepatitis B virus infection: an update for the clinician.

Authors:  José Luis Lledó; Conrado Fernández; María Luisa Gutiérrez; Sara Ocaña
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

Review 6.  Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.

Authors:  Masaru Kato; Tatsuya Atsumi
Journal:  Rheumatol Int       Date:  2015-11-16       Impact factor: 2.631

7.  Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.

Authors:  Tara N Palmore; Neeral L Shah; Rohit Loomba; Brian B Borg; Uri Lopatin; Jordan J Feld; Farooq Khokhar; Glen Lutchman; David E Kleiner; Neal S Young; Richard Childs; A John Barrett; T Jake Liang; Jay H Hoofnagle; Theo Heller
Journal:  Clin Gastroenterol Hepatol       Date:  2009-07-01       Impact factor: 11.382

8.  Fulminant hepatitis following bone marrow transplantation in hepatitis B virus carrier siblings.

Authors:  F Omata; F Ueno; Y Kushibiki; H Takahashi
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

Review 9.  Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management.

Authors:  Alessandra Zannella; Massimo Marignani; Paola Begini
Journal:  Viruses       Date:  2019-09-14       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.